Sandeep Gurram
Overview
Explore the profile of Sandeep Gurram including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
553
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Li M, Varble N, Gurram S, Long D, Valera V, Gopal N, et al.
Sci Rep
. 2024 Nov;
14(1):29168.
PMID: 39587232
To aid in the diagnosis, monitoring, and surveillance of bladder carcinoma, this study aimed to develop and test an algorithm that creates a referenceable bladder map rendered from standard cystoscopy...
12.
Esengur O, Yilmaz E, Ozyoruk K, Chen A, Lay N, Gelikman D, et al.
Clin Imaging
. 2024 Nov;
117:110363.
PMID: 39579754
Purpose: To develop and evaluate a multimodal approach including clinical parameters and biparametric MRI-based artificial intelligence (AI) model for determining the necessity of prostate biopsy in patients with PI-RADS 3...
13.
Gurram S, Rathi N
Bladder Cancer
. 2024 Nov;
10(3):167-182.
PMID: 39493816
Intravesical therapy is a critical component in the management of non-muscle-invasive bladder cancer (NMIBC), as it reduces rates of disease recurrence and progression. However, the presence of physiologic barriers in...
14.
Rathi N, Blake Z, Hyman J, Nemirovsky D, Gelikman D, Hesswani C, et al.
Urology
. 2024 Oct;
196:313-320.
PMID: 39427924
Objective: To evaluate MRI-based measurements of androgen-sensitive perineal/pelvic muscles in men with prostate cancer before and after androgen deprivation therapy (ADT) as a novel imaging marker for end-organ effects of...
15.
Esengur O, Gelikman D, Law Y, Yilmaz E, Harmon S, Merino M, et al.
Acad Radiol
. 2024 Oct;
32(2):855-863.
PMID: 39426916
Rationale And Objectives: The increasing use of focal therapy (FT) in localized prostate cancer (PCa) management requires a standardized MRI interpretation system to detect recurrent clinically significant PCa (csPCa). This...
16.
Yilmaz E, Harmon S, Law Y, Huang E, Belue M, Lin Y, et al.
Radiol Imaging Cancer
. 2024 Oct;
6(6):e240050.
PMID: 39400232
Purpose To evaluate the performance of an artificial intelligence (AI) model in detecting overall and clinically significant prostate cancer (csPCa)-positive lesions on paired external and in-house biparametric MRI (bpMRI) scans...
17.
Vocke C, Ricketts C, Pack S, Raffeld M, Hewitt S, Lebensohn A, et al.
J Med Genet
. 2024 Sep;
61(11):1026-1030.
PMID: 39317422
von Hippel-Lindau (VHL) is an autosomal-dominant hereditary tumour susceptibility disease associated with pathogenic germline variants in the tumour suppressor gene. VHL patients are at increased risk of developing multiple benign...
18.
Chandran E, Iannantuono G, Atiq S, Akbulut D, Sinaii N, Simon N, et al.
BMJ Oncol
. 2024 Aug;
3(1).
PMID: 39086924
Background: Mismatch repair deficiency (dMMR) and microsatellite instability-high (MSI-H) occur in a subset of cancers and have been shown to confer sensitivity to immune checkpoint inhibition (ICI); however, there is...
19.
Lin Y, Belue M, Yilmaz E, Law Y, Merriman K, Phelps T, et al.
Abdom Radiol (NY)
. 2024 Jul;
49(8):2891-2901.
PMID: 38958754
Objective: To assess impact of image quality on prostate cancer extraprostatic extension (EPE) detection on MRI using a deep learning-based AI algorithm. Materials And Methods: This retrospective, single institution study...
20.
Apolo A, Girardi D, Niglio S, Nadal R, Kydd A, Simon N, et al.
J Clin Oncol
. 2024 Jul;
42(25):3033-3046.
PMID: 38954785
Purpose: Cabozantinib and nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) have shown promising efficacy and safety in patients with metastatic urothelial carcinoma (mUC), metastatic renal cell carcinoma (mRCC), and rare...